VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

BTOG 2022 Summer Meeting | The centralization of molecular testing

John Gosney • 8 Jul 2022
BTOG 2022 Summer Meeting
Lung Cancer
Molecular Profiling

John Gosney, BSc, MBChB, Liverpool University Hospitals NHST, UK, discusses the benefits of centralizing genomic testing. Additionally, the challenges involved in the implementation of molecular testing are reviewed and future directions are discussed. This interview took place at the BTOG 2022 Summer Meeting congress in London.

More from John Gosney

1:59
The importance of biological understanding for disease management
John Gosney • 8 Jul 2022
1:51
Lessons learnt from a UK lung SABR rollout program
John Gosney • 8 Jul 2022

Related Videos

1:49
Building a clinical research platform to capture and leverage data from cancer care in Germany
Frank Griesinger
2:24
Advancing lung cancer therapy: from palliative chemotherapy to immunotherapy
James Spicer
0:45
How to discuss immunotherapy as a treatment option with lung cancer patients
Rolf Stahel
2:43
Clinical factors in the selection of patients for first-line immunotherapy of lung cancer
Benjamin Besse
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals